StockData
Champions Oncology, Inc. logo

Champions Oncology, Inc. (CSBR) stock

CSBRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends April 30
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jul 31, 2026Last filing: 10-Q on Sep 11, 2026Score 10/30245% above fair value
$4.68−0.03 (-0.53%)

Close on Nov 16, 2026Market cap $65.14MP/E –Yield –

Champions Oncology gross margin

Gross margin is gross profit as a percentage of revenue.

Champions Oncology's gross margin for the twelve months ending Jul 31, 2026 was 49.8%. For fiscal 2026 it was 48.0%, against 50.1% the year before. The highest annual figure on record is 51.9% in fiscal 2022.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2026Apr 30, 202648.0%−2.1
FY2025Apr 30, 202550.1%+8.8
FY2024Apr 30, 202441.4%−3.8
FY2023Apr 30, 202345.2%−6.7
FY2022Apr 30, 202251.9%+4.1
FY2021Apr 30, 202147.7%+0.7
FY2020Apr 30, 202047.1%–

Quarterly gross margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q1 FY2027CQ2 2026Jul 31, 202650.5%+7.7
Q4 FY2026CQ1 2026Apr 30, 202650.8%+9.6
Q3 FY2026CQ4 2025Jan 31, 202646.7%−14.5
Q2 FY2026CQ3 2025Oct 31, 202551.7%+6.8
Q1 FY2026CQ2 2025Jul 31, 202542.9%−6.8
Q4 FY2025CQ1 2025Apr 30, 202541.1%−7.1
Q3 FY2025CQ4 2024Jan 31, 202561.2%+26.5
Q2 FY2025CQ3 2024Oct 31, 202444.9%+2.1
Q1 FY2025CQ2 2024Jul 31, 202449.7%+10.9
Q4 FY2024CQ1 2024Apr 30, 202448.2%+4.4
Q3 FY2024CQ4 2023Jan 31, 202434.7%−5.0
Q2 FY2024CQ3 2023Oct 31, 202342.8%−5.1
Q1 FY2024CQ2 2023Jul 31, 202338.8%−9.9
Q4 FY2023CQ1 2023Apr 30, 202343.9%−7.8
Q3 FY2023CQ4 2022Jan 31, 202339.7%−11.7
Q2 FY2023CQ3 2022Oct 31, 202247.9%−4.5
Q1 FY2023CQ2 2022Jul 31, 202248.7%−3.4
Q4 FY2022CQ1 2022Apr 30, 202251.7%+7.0
Q3 FY2022CQ4 2021Jan 31, 202251.4%−5.8
Q2 FY2022CQ3 2021Oct 31, 202152.4%+8.2
Q1 FY2022CQ2 2021Jul 31, 202152.0%+7.9
Q4 FY2021CQ1 2021Apr 30, 202144.7%+2.3
Q3 FY2021CQ4 2020Jan 31, 202157.2%+5.2
Q2 FY2021CQ3 2020Oct 31, 202044.2%−4.9
Q1 FY2021CQ2 2020Jul 31, 202044.1%−0.2
Q4 FY2020CQ1 2020Apr 30, 202042.4%−4.3
Q3 FY2020CQ4 2019Jan 31, 202052.0%+3.6
Q2 FY2020CQ3 2019Oct 31, 201949.1%−1.4
Q1 FY2020CQ2 2019Jul 31, 201944.3%−7.0
Q3 FY2019CQ4 2018Jan 31, 201946.7%−2.3
Q2 FY2019CQ3 2018Oct 31, 201848.4%+0.9
Q1 FY2019CQ2 2018Jul 31, 201850.5%–
Q3 FY2018CQ4 2017Jan 31, 201851.3%–
Q2 FY2018CQ3 2017Oct 31, 201749.0%–
Q1 FY2018CQ2 2017Jul 31, 201747.5%–

More Champions Oncology figures

See a number that looks wrong?